Paper41449309
Multiple system atrophy: advances in pathogenesis and emerging therapeutic strategies.
Chen Z and 2 others. J Neurol, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Multiple system atrophy: advances in pathogenesis and emerging therapeutic strategies. Papers, record 41449309. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41449309
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Multiple System Atrophy | Major topic |
| Humans | |
| alpha-Synuclein | |
| Animals |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022SKLID306 | State Key Laboratory of Infectious Disease Prevention and Control | PubMed | ||
| T2488101 | National Natural Science Foundation of China | PubMed | ||
| 82071417 | National Natural Science Foundation of China | PubMed |
Source PubMed
References178
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25498732 | Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial. | Lancet Neurol | 2015 | https://conductscience.org/library/papers/25498732 | PubMed |
| 2 | 39405585 | Multiple System Atrophy: Pathology, Pathogenesis, and Path Forward. | Annu Rev Pathol | 2025 | https://conductscience.org/library/papers/39405585 | PubMed |
| 3 | 32882100 | A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy. | Mov Disord | 2020 | https://conductscience.org/library/papers/32882100 | PubMed |
| 4 | 36097244 | Clinical and Genetic Features of Multiplex Families with Multiple System Atrophy and Parkinson's Disease. | Cerebellum | 2024 | https://conductscience.org/library/papers/36097244 | PubMed |
| 5 | 23116538 | Treatment of multiple system atrophy using intravenous immunoglobulin. | BMC Neurol | 2012 | https://conductscience.org/library/papers/23116538 | PubMed |
| 6 | 14748560 | Microglial activation parallels system degeneration in multiple system atrophy. | J Neuropathol Exp Neurol | 2004 | https://conductscience.org/library/papers/14748560 | PubMed |
| 7 | 31751571 | FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models. | Exp Neurol | 2020 | https://conductscience.org/library/papers/31751571 | PubMed |
| 8 | 40619658 | The Fragile Balance: Autophagy's Role in Neurodegenerative Disease Progression. | Curr Neuropharmacol | 2026 | https://conductscience.org/library/papers/40619658 | PubMed |
| 9 | 35210396 | Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy. | Transl Psychiatry | 2022 | https://conductscience.org/library/papers/35210396 | PubMed |
| 10 | 32576494 | Cerebrospinal fluid myelin basic protein is elevated in multiple system atrophy. | Parkinsonism Relat Disord | 2020 | https://conductscience.org/library/papers/32576494 | PubMed |
| 11 | 35903017 | Neurofilament light levels predict clinical progression and death in multiple system atrophy. | Brain | 2022 | https://conductscience.org/library/papers/35903017 | PubMed |
| 12 | 27629089 | A genome-wide association study in multiple system atrophy. | Neurology | 2016 | https://conductscience.org/library/papers/27629089 | PubMed |
| 13 | 31649208 | Differentiation of Human Mesenchymal Stem Cells towards Neuronal Lineage: Clinical Trials in Nervous System Disorders. | Biomol Ther (Seoul) | 2020 | https://conductscience.org/library/papers/31649208 | PubMed |
| 14 | 31434803 | Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies. | JCI Insight | 2019 | https://conductscience.org/library/papers/31434803 | PubMed |
| 15 | 37488838 | Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings. | Neural Regen Res | 2024 | https://conductscience.org/library/papers/37488838 | PubMed |
| 16 | 33941284 | Robust α-synuclein pathology in select brainstem neuronal populations is a potential instigator of multiple system atrophy. | Acta Neuropathol Commun | 2021 | https://conductscience.org/library/papers/33941284 | PubMed |
| 17 | 28659169 | The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease. | Acta Neuropathol Commun | 2017 | https://conductscience.org/library/papers/28659169 | PubMed |
| 18 | 36922526 | Head-to-head comparison of 6 plasma biomarkers in early multiple system atrophy. | NPJ Parkinsons Dis | 2023 | https://conductscience.org/library/papers/36922526 | PubMed |
| 19 | 28053341 | Gut-brain axis in 2016: Brain-gut-microbiota axis - mood, metabolism and behaviour. | Nat Rev Gastroenterol Hepatol | 2017 | https://conductscience.org/library/papers/28053341 | PubMed |
| 20 | 24907278 | How epigallocatechin gallate can inhibit α-synuclein oligomer toxicity in vitro. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24907278 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42589103 | Natural Product-Derived Carbon Dots in Neurodegenerative Diseases: Advances in Blood-Brain-Barrier-Related Delivery, Neuroprotection, and Theranostics. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42589103 | PubMed |
| 42463685 | Plasma ceramide ratios define metabolic-inflammatory associations with cognitive impairment in Parkinson's disease. | NPJ Parkinsons Dis | 2026 | https://conductscience.org/library/papers/42463685 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SNCA | 6622 | PubTator's text mining | https://conductscience.org/library/genes/6622 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41449309
GET https://conductscience.org/api/papers/v1/41449309/references?page=2